Green Cross Medical Science's quarterly market cap
increased
from Sep. 2023 (₩84,645 Mil) to Dec. 2023 (₩100,563 Mil) but then
declined
from Dec. 2023 (₩100,563 Mil) to Mar. 2024 (₩93,289 Mil).
Green Cross Medical Science's annual market cap
declined
from Dec. 2021 (₩152,317 Mil) to Dec. 2022 (₩121,856 Mil) and
declined
from Dec. 2022 (₩121,856 Mil) to Dec. 2023 (₩100,563 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Green Cross Medical Science's Enterprise Value for Today is ₩104,408 Mil.
Green Cross Medical Science Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Green Cross Medical Science's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Green Cross Medical Science's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Cross Medical Science's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Cross Medical Science's Market Cap distribution charts can be found below:
* The bar in red indicates where Green Cross Medical Science's Market Cap falls into.
Green Cross Medical Science Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Medical Science (XKRX:142280) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Green Cross Medical Science Market Cap Related Terms
Thank you for viewing the detailed overview of Green Cross Medical Science's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Green Cross Medical Science (XKRX:142280) Business Description
Green Cross Medical Science Corp is a total medical device company. It is engaged in the blood glucose business, kidney hemodialysis business, and blood bag business with the application of its know-how in in-vitro diagnostics. The product portfolio offered by the organization includes diagnostic reagents, diagnostic instruments, blood bag, home medical devices, blood dialysis products and HbA1c/BGMS.
Green Cross Medical Science (XKRX:142280) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:142280 has been successfully added to your 